Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Study

The impact of drug error reduction software on preventing harmful adverse drug events in England: a retrospective database study.

Sutherland A, Gerrard WS, Patel A, et al. The impact of drug error reduction software on preventing harmful adverse drug events in England: a retrospective database study. BMJ Open Qual. 2022;11(3):e001708. doi:10.1136/bmjoq-2021-001708.

Save
Print
August 24, 2022
Sutherland A, Gerrard WS, Patel A, et al. BMJ Open Qual. 2022;11(3):e001708.
View more articles from the same authors.

Smart pump software can improve medication safety but can also introduce patient safety hazards, such as alert fatigue. In this study, dose error reduction software (DERS) was implemented across two large UK National Health Service (NHS) institutes for one year. Findings indicate that compliance with DERS was 45%, but across one year of implementation, severe harm or death was avoided in up to 110 patients.

Save
Print
Cite
Citation

Sutherland A, Gerrard WS, Patel A, et al. The impact of drug error reduction software on preventing harmful adverse drug events in England: a retrospective database study. BMJ Open Qual. 2022;11(3):e001708. doi:10.1136/bmjoq-2021-001708.

Related Resources From the Same Author(s)